390 related articles for article (PubMed ID: 16641043)
21. Atherogenic lipid profiles in rheumatoid arthritis.
White D; Fayez S; Doube A
N Z Med J; 2006 Aug; 119(1240):U2125. PubMed ID: 16924276
[TBL] [Abstract][Full Text] [Related]
22. Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis.
García-Gómez C; Nolla JM; Valverde J; Gómez-Gerique JA; Castro MJ; Pintó X
J Rheumatol; 2009 Jul; 36(7):1365-70. PubMed ID: 19369465
[TBL] [Abstract][Full Text] [Related]
23. Infliximab but not methotrexate induces extra-high levels of VLDL-triglyceride in patients with rheumatoid arthritis.
Saiki O; Takao R; Naruse Y; Kuhara M; Imai S; Uda H
J Rheumatol; 2007 Oct; 34(10):1997-2004. PubMed ID: 17787045
[TBL] [Abstract][Full Text] [Related]
24. Early and late effect of infliximab on circulating dendritic cells phenotype in rheumatoid arthritis patients.
Balanescu A; Radu E; Nat R; Regalia T; Bojinca V; Ionescu R; Balanescu S; Savu C; Predeteanu D
Int J Clin Pharmacol Res; 2005; 25(1):9-18. PubMed ID: 15864873
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab.
Lequerré T; Jouen F; Brazier M; Clayssens S; Klemmer N; Ménard JF; Mejjad O; Daragon A; Tron F; Le Loët X; Vittecoq O
Rheumatology (Oxford); 2007 Mar; 46(3):446-53. PubMed ID: 16899502
[TBL] [Abstract][Full Text] [Related]
26. Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis.
Seriolo B; Paolino S; Sulli A; Fasciolo D; Cutolo M
Ann N Y Acad Sci; 2006 Jun; 1069():414-9. PubMed ID: 16855168
[TBL] [Abstract][Full Text] [Related]
27. Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problem.
Soubrier M; Zerkak D; Dougados M
J Rheumatol; 2006 Sep; 33(9):1766-9. PubMed ID: 16845709
[TBL] [Abstract][Full Text] [Related]
28. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
[TBL] [Abstract][Full Text] [Related]
29. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Symmons DP; Watson KD; Silman AJ;
Arthritis Rheum; 2006 Jun; 54(6):1786-94. PubMed ID: 16736520
[TBL] [Abstract][Full Text] [Related]
31. Titration of infliximab treatment in rheumatoid arthritis patients based on response patterns.
Flendrie M; Creemers MC; van Riel PL
Rheumatology (Oxford); 2007 Jan; 46(1):146-9. PubMed ID: 16782732
[TBL] [Abstract][Full Text] [Related]
32. Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions.
Choy E; Sattar N
Ann Rheum Dis; 2009 Apr; 68(4):460-9. PubMed ID: 19286905
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor-α inhibitor use is not associated with lipid changes in rheumatoid arthritis.
Bili A; Morris SJ; Sartorius JA; Kirchner HL; Antohe JL; Dancea S; Wasko MC
J Rheumatol; 2012 May; 39(5):946-8. PubMed ID: 22467937
[TBL] [Abstract][Full Text] [Related]
34. Predictors of infusion reactions during infliximab treatment in patients with arthritis.
Kapetanovic MC; Larsson L; Truedsson L; Sturfelt G; Saxne T; Geborek P
Arthritis Res Ther; 2006; 8(4):R131. PubMed ID: 16869978
[TBL] [Abstract][Full Text] [Related]
35. Infliximab improves vascular stiffness in patients with rheumatoid arthritis.
Wong M; Oakley SP; Young L; Jiang BY; Wierzbicki A; Panayi G; Chowienczyk P; Kirkham B
Ann Rheum Dis; 2009 Aug; 68(8):1277-84. PubMed ID: 18930987
[TBL] [Abstract][Full Text] [Related]
36. Infliximab dosage and infusion frequency in clinical practice: experiences in the Stockholm biologics registry STURE.
van Vollenhoven RF; Klareskog L
Scand J Rheumatol; 2007; 36(6):418-23. PubMed ID: 18092261
[TBL] [Abstract][Full Text] [Related]
37. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.
Hadaegh F; Harati H; Ghanbarian A; Azizi F
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):571-7. PubMed ID: 16874147
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy.
Riddler SA; Li X; Chu H; Kingsley LA; Dobs A; Evans R; Palella F; Visscher B; Chmiel JS; Sharrett A
HIV Med; 2007 Jul; 8(5):280-7. PubMed ID: 17561873
[TBL] [Abstract][Full Text] [Related]
39. Effects of tumor necrosis factor alpha inhibition with infliximab on lipid levels and insulin resistance in patients with inflammatory bowel disease.
Koutroubakis IE; Oustamanolakis P; Malliaraki N; Karmiris K; Chalkiadakis I; Ganotakis E; Karkavitsas N; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):283-8. PubMed ID: 19279474
[TBL] [Abstract][Full Text] [Related]
40. IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis.
Vis M; Bos WH; Wolbink G; Voskuyl AE; Twisk JW; Van de Stadt R; Hamann D; Dijkmans BA; Lems WF
J Rheumatol; 2008 Mar; 35(3):425-8. PubMed ID: 18322974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
